Status:
COMPLETED
Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume
Lead Sponsor:
Indonesia University
Conditions:
Diabetic Retinopathy
Dyslipidemias
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Lipid levels in the blood are proposed to play a role in the progression of diabetic retinopathy. Lipid levels can be controlled with dyslipidemic drugs, such as fenofibrate. Fenofibrate is known to p...
Detailed Description
This study was a prospective, double-blind, controlled clinical trial. The study was conducted from 2016 to 2017 at Vitreo-retina Clinic, Department of Ophthalmology, RSCM Kirana. The subjects were no...
Eligibility Criteria
Inclusion
- Adults with type 2 DM
- Confirmed DR (with bio-microscopy examination and fundus photos of both eyes)
- Dyslipidemia or normal lipid profile with treatment
- Sign informed consent
Exclusion
- Subjects with severe renal failure
- Subjects with allergy towards fenofibrate
- Pregnant women
- Subjects who have undergone laser photocoagulation treatment or intravitreal injection in last 6 months
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04885153
Start Date
November 1 2016
End Date
July 1 2017
Last Update
May 13 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.